.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Merck
US Department of Justice
Baxter
QuintilesIMS
Cantor Fitzgerald
Boehringer Ingelheim
UBS
Moodys
Medtronic

Generated: November 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,754,257

« Back to Dashboard

Claims for Patent: 8,754,257

Title:Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Abstract: The present invention discloses a pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A manufacturing and quality control process for making a pharmaceutical-grade ferric citrate that consistently complies with the established Manufacture Release Specification is also disclosed. The pharmaceutical-grade ferric organic compounds are suitable for treating disorders characterized by elevated serum phosphate levels.
Inventor(s): Chan; Keith (Rockville, MD), Town; Winston (Hong Kong, CN)
Assignee: Panion & BF Biotech Inc. (TW)
Application Number:13/661,558
Patent Claims: 1. A pharmaceutical composition comprising a form of ferric citrate having an intrinsic dissolution rate of 1.88-4.0 mg/cm.sup.2/min and a pharmaceutically suitable carrier, wherein the ferric citrate is present in an amount effective to reduce serum phosphate levels.

2. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is from 2 grams per day to 30 grams per day.

3. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is from 4 grams per day to 15 grams per day.

4. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is from 2 grams per day to 12 grams per day.

5. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is selected from 2 grams per day, 4 grams per day and 6 grams per day.

6. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is 1 gram per day.

7. The pharmaceutical composition of claim 1, wherein the effective amount of ferric citrate is 500 mg per unit dosage form.

8. A pharmaceutical composition comprising 500 mg of a form of ferric citrate having an intrinsic dissolution rate of 1.88-4.0 mg/cm.sup.2/min, and a pharmaceutically suitable carrier, wherein the pharmaceutical composition is in a capsule dosage form.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Novartis
QuintilesIMS
Moodys
Baxter
Covington
Queensland Health
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot